Verisk Health announced that Highmark Inc. has implemented Verisk Health’s analytics and clinical intelligence solution to fuel Highmark’s internal care management process. Highmark, a leading health plan serving more than 4.9 million people, will use the solution to improve the identification and stratification of high-risk populations to optimize the outcomes of its intervention and member engagement initiatives. Verisk Health is a global leader in using clinical analytics and advanced technology to help customers understand and use their data to drive key business goals.
"Highmark is focused on delivering the right care to the right person. The Verisk Health intelligence solution allows us to identify proactively those individuals as well as pinpoint the appropriate course of action,” said Brian Day, Ph.D., director of advanced analytics at Highmark. “The Verisk Health Identification and Stratification engine feeds our care management workflow tool, supporting clinical analysis and targeted outreach. That leads to medically sound, financially effective interventions for both our commercial and Medicare populations.”
As part of the program, Verisk Health will combine claims data with care management information, health risk assessment details, and other key elements to create monthly extracts that support Highmark’s clinical initiatives. In addition, Highmark will link directly to member-level information within its care management workflow program to allow clinicians, at the point of outreach, to gain a complete view of a member’s care, including medication compliance and quality gaps.
"Highmark has a long track record of driving business performance through the efficient integration of risk management technologies and internal processes,” said Nathan Gunn, MD, chief operating officer at Verisk Health. “The organization is now implementing an innovative approach to population health management, which will improve outcomes for its members, its clients, and its bottom line.”
Mr. Day will discuss details and preliminary results of Highmark’s work with Verisk Health at the AHIP Institute 2012 conference in June. For more information, visit http://www.ahip.org/Conferences/Institute2012/.
The most recent agreement continues Verisk Health’s long-standing relationship with Highmark, which has used the company’s DxCG Risk Solutions for more than ten years to assess population risk, identify cost drivers, and improve clinical outcomes. Highmark also uses Verisk Health’s Performance Measurement solution to optimize HEDIS and quality compliance.
About Verisk Health
Verisk Health, a subsidiary of Verisk Analytics (Nasdaq:VRSK), helps organizations identify, manage, and mitigate healthcare risk to improve quality, reduce costs, and maximize profitability. Our data-driven risk assessment technologies and business decision analytics enable clients to proactively seize opportunities for improving clinical, financial, and performance results, including care management; risk identification and stratification; HEDIS compliance; benefit program measurement; fraud, waste, and abuse prevention; payment accuracy; and revenue cycle management. For more information, visit www.veriskhealth.com.
Highmark Inc., based in Pittsburgh, is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. Highmark serves 4.9 million members in Pennsylvania, West Virginia, and Delaware through the company’s healthcare benefits business and is one of the largest Blue plans in the nation. Highmark has 19,500 employees across the country and provides a broad range of health- and wellness-related services through subsidiary and affiliate companies. For more information, visit www.highmark.com.